Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a biotechnology company in the healthcare sector on NASDAQ, led by Lakhmir Chawla, M.D., with a market cap of $5.5M. As of Q3 2025, 16% of shares are held by 9 institutional investors, with SABBY MANAGEMENT, LLC as the largest holder at 8.85%.
Overview
Overview of institutional ownership in REVB as of Q3 2025 with a market cap of $3.3M
All Institutions
- Institutions
- 9
- Value Held
- $539.7K
- Shares Held
- 380.1K
- Avg Position
- $60.0K
- Median Position
- $758.0
Hedge Funds
- Hedge Funds
- 1
- Value Held
- $113.6K
- Shares Held
- 80.0K
- Avg Position
- $113.6K
- Median Position
- $113.6K
Ownership Breakdown
Based on market cap of $3.3M as of Q3 2025. Institutional (non-HF) excludes hedge funds to avoid double counting.
Biggest Investors
Institutions with the largest positions in REVB as of Q3 2025
| Institution | Position Value |
|---|---|
S SABBY MANAGEMENT, LLC Institution | $294.0K 1.60% of portfolio |
 ARMISTICE CAPITAL, LLC Hedge Fund•Long/Short | $113.6K 0.00% of portfolio |
D DRW Securities, LLC Institution | $109.7K 0.01% of portfolio |
J JANE STREET GROUP, LLC Institution | $21.0K 0.00% of portfolio |
T Tower Research Capital LLC Institution | $758.0 0.00% of portfolio |
S SBI Securities Co., Ltd. Institution | $650.0 0.00% of portfolio |
 BANK OF AMERICA CORP /DE/ Institution | $20.0 0.00% of portfolio |
 UBS Group AG Institution | $3.0 0.00% of portfolio |
 CITIGROUP INC Institution | $1.0 0.00% of portfolio |
R ROYAL BANK OF CANADA Institution | - 0.00% of portfolio |
Net Capital Flow
Institutional buying and selling activity for REVB in Q3 2025
- Traded
- +$496.1K
- Buyers
- 7
- Sellers
- 4
- Total Bought
- +$507.2K
- Total Sold
- −$11.1K
- Avg Position
- $49.1K
Biggest Buyers
| Institution | Net Bought |
|---|---|
S SABBY MANAGEMENT, LLC Institution | +$262.9K +185.1K shares |
ARMISTICE CAPITAL, LLC Hedge Fund•Long/Short | +$113.6K +80.0K shares |
D DRW Securities, LLC Institution | +$109.7K +77.3K shares |
J JANE STREET GROUP, LLC Institution | +$21.0K +14.8K shares |
BANK OF AMERICA CORP /DE/ Institution | +$15.7 +11.0 shares |
UBS Group AG Institution | +$3.0 +-248.3 shares |
CITIGROUP INC Institution | +$1.0 +1.0 shares |
Biggest Sellers
| Institution | Net Sold |
|---|---|
 INTL FCSTONE INC. Institution | −$7.7K −3.4K shares |
R ROYAL BANK OF CANADA Institution | −$2.6K −1.1K shares |
T Tower Research Capital LLC Institution | −$887.6 −625.3 shares |
S SBI Securities Co., Ltd. Institution | −$7.6 −5.3 shares |
Entry and Exit Activity
Institutions that initiated new positions or completely exited REVB in Q3 2025
- New Positions
- 2
- New Value
- $223.3K
- Exited Positions
- 2
- Exited Value
- $10.2K
New Positions
| Institution | Position Value |
|---|---|
ARMISTICE CAPITAL, LLC Hedge Fund•Long/Short | $113.6K 80.0K shares |
D DRW Securities, LLC Institution | $109.7K 77.3K shares |
Exited Positions
| Institution | Previous Position |
|---|---|
INTL FCSTONE INC. Institution | $7.7K 3.4K shares |
R ROYAL BANK OF CANADA Institution | $2.6K 1.1K shares |
Options Activity
Institutions with the largest Call and Put options positions in REVB as of Q3 2025
- Call Positions
- 0
- Call Value
- -
- Put Positions
- 0
- Put Value
- -
Call Positions
| Institution | Position Value |
|---|---|
| No call positions found | |
Put Positions
| Institution | Position Value |
|---|---|
| No put positions found | |
Most Committed Institutions
Institutions with REVB as the highest % of their portfolio as of Q3 2025
| Institution | Portfolio Weight |
|---|---|
S SABBY MANAGEMENT, LLC Institution | 1.60% $294.0K |
D DRW Securities, LLC Institution | 0.01% $109.7K |
ARMISTICE CAPITAL, LLC Hedge Fund•Long/Short | 0.00% $113.6K |
J JANE STREET GROUP, LLC Institution | 0.00% $21.0K |
T Tower Research Capital LLC Institution | 0.00% $758.0 |
S SBI Securities Co., Ltd. Institution | 0.00% $650.0 |
BANK OF AMERICA CORP /DE/ Institution | 0.00% $20.0 |
CITIGROUP INC Institution | 0.00% $1.0 |
UBS Group AG Institution | 0.00% $3.0 |
R ROYAL BANK OF CANADA Institution | 0.00% - |
Hedge Fund Spotlight
Discover hedge funds investing in REVB
- Portfolio Value
- $3.2B
- Positions
- 313
- Last Reported
- Q3 2025
Position in Revelation Biosciences, Inc.
- Market Value
- $113.6K
- Shares Held
- 80.0K
- Portfolio Weight
- 0.00%
- Owned Since
- 2025-Q3
| Top Holding | Sector | Market Value | Weight |
|---|---|---|---|
Biotechnology Healthcare | $201.1M | 6.38% | |
Biotechnology Healthcare | $160.7M | 5.10% | |
Drug Manufacturers - Specialty & Generic Healthcare | $135.5M | 4.30% |
